Company
Every investor coverage indicates participated in a round Servatus raised.
Companies Servatus acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Wayne Finlayson | CEO | @AuManufacturing |
Stories naming Servatus. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian Biotherapeutics has started production at a $10.4 million Coolum factory, backed by a Queensland government grant, in joint venture with Servatus, with growing export output and new jobs expected.